(Medical Xpress)—People with HIV have an elevated risk of heart attacks, diabetes and insulin problems. To compound matters, there are not many drug options to prevent those secondary problems because of ...
HIV & AIDS Mar 15, 2013 | 5 / 5 (1) | 0 |
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications Mar 14, 2013 | not rated yet | 0
Drugs that combat ageing may be available within five years, following landmark work led by an Australian researcher. The work, published in the March 8 issue of Science, finally proves that a single anti-ageing enzyme in the ...
Medical research Mar 08, 2013 | 5 / 5 (10) | 2
People who take the newest class of diabetes drugs to control blood sugar are twice as likely as those on other forms of sugar-control medication to be hospitalized with pancreatitis, Johns Hopkins researchers report.
Medications Feb 25, 2013 | 5 / 5 (2) | 1 |
(HealthDay)—The drug Byetta, approved for adults with type 2 diabetes, appears to help severely obese teens lose some weight, a small study found.
Pediatrics Feb 05, 2013 | 5 / 5 (1) | 0 |
Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, Reuben Shaw has wondered if drugs originally designed to treat metabolic diseases ...
Cancer Jan 29, 2013 | not rated yet | 0 |
(HealthDay)—The U.S. Food and Drug Administration late Friday approved three new medications to help people battle type 2 diabetes.
Medications Jan 26, 2013 | 5 / 5 (2) | 1
(Medical Xpress)—New drugs to treat diabetes are being developed by scientists at the University of Greenwich.
Diabetes Jan 16, 2013 | 5 / 5 (2) | 0
A panel of U.S. health experts ruled Thursday that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked over the long term.
Medications Jan 10, 2013 | not rated yet | 0
Federal drug reviewers think Johnson & Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.
Medications Jan 08, 2013 | not rated yet | 0
A team, led by senior author Morris J. Birnbaum, MD, PhD, the Willard and Rhoda Ware Professor of Medicine, with the Institute for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, University ...
Diabetes Jan 06, 2013 | 5 / 5 (3) | 0 |
Obese, postmenopausal women are at greater risk for developing breast cancer and their cancers tend to be more aggressive than those in lean counterparts. A University of Colorado Cancer Center study published in the December ...
Cancer Dec 19, 2012 | 5 / 5 (1) | 0
Researchers at Virginia Bioinformatics Institute at Virginia Tech have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.
Diseases, Conditions, Syndromes Nov 30, 2012 | 5 / 5 (1) | 0 |
(AP)—Drugmakers Bristol-Myers Squibb Co. and AstraZeneca PLC say their experimental diabetes pill has gotten its first major approval, in the European Union.
Medications Nov 14, 2012 | not rated yet | 0
A direct, head-to-head comparison of two of the newer treatments available for type 2 diabetes yielded mixed results.
Diabetes Nov 06, 2012 | 5 / 5 (2) | 0 |